Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6444866rdf:typepubmed:Citationlld:pubmed
pubmed-article:6444866lifeskim:mentionsumls-concept:C0700038lld:lifeskim
pubmed-article:6444866lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:6444866lifeskim:mentionsumls-concept:C0001268lld:lifeskim
pubmed-article:6444866lifeskim:mentionsumls-concept:C0002680lld:lifeskim
pubmed-article:6444866lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:6444866lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:6444866pubmed:issue2lld:pubmed
pubmed-article:6444866pubmed:dateCreated1980-6-25lld:pubmed
pubmed-article:6444866pubmed:abstractTextPelvic inflammatory disease (PID) may be caused by anaerobic bacteria and or gonococcus and therefore the efficacy of two antibiotics, ampicillin (AMP) and spectinomycin (SPM) commonly used in this setting was examined against 370 isolates of anaerobic bacteria. At the highest therapeutically achievable serum levels, AMP (16 micrograms/ml) inhibited 83% of all anaerobes and 70% of Bacterioides fragilis, and SPM (128 micrograms/ml) inhibited 98% of all anaerobes and 95% of B. fragilis strains tested. It therefore appears that both AMP and SPM may have a place in the treatment of PID. In our study, greater percentage of anaerobes were susceptible to SPM than previously reported. We used the 'glove box' technique used for testing the susceptibility of anaerobes.lld:pubmed
pubmed-article:6444866pubmed:languageenglld:pubmed
pubmed-article:6444866pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6444866pubmed:citationSubsetIMlld:pubmed
pubmed-article:6444866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6444866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6444866pubmed:statusMEDLINElld:pubmed
pubmed-article:6444866pubmed:issn0009-3157lld:pubmed
pubmed-article:6444866pubmed:authorpubmed-author:VEISR ARAlld:pubmed
pubmed-article:6444866pubmed:authorpubmed-author:RoyIIlld:pubmed
pubmed-article:6444866pubmed:authorpubmed-author:ThadepalliHHlld:pubmed
pubmed-article:6444866pubmed:authorpubmed-author:BachV TVTlld:pubmed
pubmed-article:6444866pubmed:issnTypePrintlld:pubmed
pubmed-article:6444866pubmed:volume26lld:pubmed
pubmed-article:6444866pubmed:ownerNLMlld:pubmed
pubmed-article:6444866pubmed:authorsCompleteYlld:pubmed
pubmed-article:6444866pubmed:pagination111-5lld:pubmed
pubmed-article:6444866pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:meshHeadingpubmed-meshheading:6444866-...lld:pubmed
pubmed-article:6444866pubmed:year1980lld:pubmed
pubmed-article:6444866pubmed:articleTitleIn vitro susceptibility of anaerobic flora of the female genital tract to ampicillin compared to spectinomycin.lld:pubmed
pubmed-article:6444866pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6444866pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6444866lld:pubmed